Dolby Laboratories, Inc. (DLB) is a Information Technology Services company in the Technology sector, currently trading at $61.94. It has a SharesGrow Score of 75/100, indicating a strong investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of DLB = $128.70 (+107.8% from the current price, the stock appears undervalued). Analyst consensus target is DLB = $85 (+37.2% upside).
Valuation: DLB trades at a trailing Price-to-Earnings (P/E) of 23.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.52.
Financials: revenue is $1.3B, +10.9%/yr average growth. Net income is $255M, growing at +18.4%/yr. Net profit margin is 18.9% (healthy). Gross margin is 88.1% (-0.3 pp trend).
Balance sheet: total debt is $39M against $2.6B equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 3.17 (strong liquidity). Debt-to-assets is 1.2%. Total assets: $3.2B.
Analyst outlook: 8 / 17 analysts rate DLB as buy (47%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 51/100 (Partial), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 70/100 (Pass), Future 52/100 (Partial), Income 70/100 (Pass).
